Immix Biopharma, Inc.

NASDAQ:IMMX

2.18 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q1
Assets:
Current Assets:
Cash & Cash Equivalents 19.6923.97529.31917.5119.58212.65411.46313.43716.91718.40219.06117.6440.0380.111-0.3910.391-0.734
Short Term Investments 000000000000000.78201.468
Cash and Short Term Investments 19.6923.97529.31917.5119.58212.65411.46313.43716.91718.40219.06117.6440.0380.1110.3910.3910.734
Net Receivables 1.9751.9801.1720.6520.2970.3220.2560.1820.1650.0640.0260.1890000
Inventory 00000000000-0.02600000
Other Current Assets 1.091.3753.5961.1062.0972.5571.2481.2050.2920.5160.8880.5160.0160.00700.0140
Total Current Assets 22.75627.33132.91519.78822.33215.50713.03314.89817.39119.08320.01218.1860.2430.2920.3910.5320.734
Non-Current Assets:
Property, Plant & Equipment, Net 2.3661.4851.4120.050.040.0030.0030.0040.0040.0050.0050.0060.0060.00700.0070
Goodwill 00000000000000000
Intangible Assets 00000000000000000
Goodwill and Intangible Assets 00000000000000000
Long Term Investments 00000000000000000
Tax Assets 00000000000000000
Other Non-Current Assets 0.020.020.020.0870.1030.0570.1750.00700000.2460.053-0.3910-0.734
Total Non-Current Assets 2.3861.5051.4320.1370.1430.0590.1780.010.0040.0050.0050.0060.2520.06-0.3910.007-0.734
Total Assets 25.14228.83634.34819.92522.47515.56613.21114.90817.39519.08820.01718.1920.4950.35200.540
Liabilities & Equity:
Current Liabilities:
Account Payables 3.2892.3473.5131.4331.5662.3961.4730.1430.6460.9770.3060.1430.6180.18300.2520
Short Term Debt 0.0630.0970.03400000000.050.054.14.104.10
Tax Payables 00000000000000000
Deferred Revenue 0-0.048000000000-0.1930.4360.40300.3430
Other Current Liabilities 3.2131.4592.112.2891.259001.13000.0090.0091.7461.71300.9180
Total Current Liabilities 6.5653.9025.6573.7222.8262.3961.4731.2730.6460.9770.3650.2026.4645.99605.270
Non-Current Liabilities:
Long Term Debt 1.0261.0431.0590000000000.1470.127000
Deferred Revenue Non-Current 00000000000000000
Deferred Tax Liabilities Non-Current 00000000000000000
Other Non-Current Liabilities 00000000.47500000.080.08000
Total Non-Current Liabilities 1.0261.0431.05900000.4750.64600.35600.2270.207000
Total Liabilities 7.5914.9456.7163.7222.8262.3961.4731.7480.6460.9770.3650.2026.6916.20205.270
Equity:
Preferred Stock 00000000000000000
Common Stock 0.0030.0030.0030.0020.0020.0020.0010.0010.0010.0010.0010.00100000
Retained Earnings -70.213-63.063-58.67-53.411-48.322-44.041-40.465-37.985-34.185-32.65-31.088-29.756-7-6.5970-5.3720
Accumulated Other Comprehensive Income/Loss 0.1920.1170.090.1350.0470.0810.0830.0870.0620.1020.1410.1250.1240.127-4.7310.132-3.646
Other Total Stockholders Equity 87.56986.83586.49369.6868.04757.18652.15251.05750.87150.65750.59847.6190.680.61800.5090
Total Shareholders Equity 17.55123.89127.91516.40519.77413.22711.77113.1616.74918.11119.65217.99-6.196-5.851-4.731-4.731-3.646
Total Equity 17.55123.89127.63216.20319.64913.17111.73913.1616.74918.11119.65217.99-6.196-5.851-4.731-4.731-3.646
Total Liabilities & Shareholders Equity 25.14228.83634.34819.92522.47515.56613.21114.90817.39519.08820.01718.1920.4950.352-4.7310.54-3.646